BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 334070)

  • 1. Norleucine accumulation by a norleucine-resistant mutant of Serratia marcescens.
    Kisumi M; Sugiura M; Chibata I
    Appl Environ Microbiol; 1977 Aug; 34(2):135-8. PubMed ID: 334070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of norvaline, norleucine, and homoisoleucine in Serratia marcescens.
    Kisumi M; Sugiura M; Chibata I
    J Biochem; 1976 Aug; 80(2):333-9. PubMed ID: 794063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norvaline accumulation by regulatory mutants of Serratia marcescens.
    Kisumi M; Sugiura M; Takagi T; Chibata I
    J Antibiot (Tokyo); 1977 Jan; 30(1):111-7. PubMed ID: 320169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A norleucine-resistant mutant of Salmonella typhimurium with a possible defect in valine uptake or regulation.
    Hobson AC
    J Gen Microbiol; 1974 Jun; 82(2):425-9. PubMed ID: 4609030
    [No Abstract]   [Full Text] [Related]  

  • 5. L-Norvaline and L-homoisoleucine formation by Serratia marcescens,
    Kisumi M; Sugiura M; Kato J; Chibata I
    J Biochem; 1976 May; 79(5):1021-8. PubMed ID: 783153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-methylnorleucine, an antimetabolite produced by Serratia marcescens.
    Sugiura M; Kisumi M; Chibata I
    J Antibiot (Tokyo); 1981 Oct; 34(10):1278-82. PubMed ID: 7031030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valine accumulation by alpha-aminobutyric acid-resistant mutants of Serratia marcescens.
    Kisumi M; Komatsubara S; Chibata I
    J Bacteriol; 1971 May; 106(2):493-9. PubMed ID: 4929861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threonine production by regulatory mutants of Serratia marcescens.
    Komatsubara S; Kisumi M; Murata K; Chibata I
    Appl Environ Microbiol; 1978 May; 35(5):834-40. PubMed ID: 350154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine accumulation by isoleucine revertants of Serratia marcescens resistant to -aminobutyric acid: lack of both feedback inhibition and repression.
    Kisumi M; Komatsubara S; Chibata I
    J Biochem; 1973 Jan; 73(1):107-15. PubMed ID: 4570366
    [No Abstract]   [Full Text] [Related]  

  • 10. Biosynthetic pathway of beta-methylnorleucine, an antimetabolite produced by Serratia marcescens.
    Sugiura M; Kisumi M; Chibata I
    J Antibiot (Tokyo); 1981 Oct; 34(10):1283-9. PubMed ID: 7031031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of isoleucine hydroxamate-mediated growth inhibition and improvement of isoleucine-producing strains of Serratia marcescens.
    Kisumi M; Komatsubara S; Chibata I
    Appl Environ Microbiol; 1977 Dec; 34(6):647-53. PubMed ID: 339830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in isoleucine accumulation by alpha-aminobutyric acid-resistant mutants of Serratia marcescens.
    Kisumi M; Kato J; Komatsubara S; Chibata I
    Appl Microbiol; 1971 Apr; 21(4):569-74. PubMed ID: 4930271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathway for isoleucine formation form pyruvate by leucine biosynthetic enzymes in leucine-accumulating isoleucine revertants of Serratia marcescens.
    Kisumi M; Komatsubara S; Chibata I
    J Biochem; 1977 Jul; 82(1):95-103. PubMed ID: 142769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoleucine accumulation by regulatory mutants of Serratia marcescens: lack of both feedback inhibition and repression.
    Kisumi M; Komatsubara S; Sugiura M; Chibata I
    J Bacteriol; 1972 May; 110(2):761-3. PubMed ID: 4553844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coli.
    Tsai LB; Lu HS; Kenney WC; Curless CC; Klein ML; Lai PH; Fenton DM; Altrock BW; Mann MB
    Biochem Biophys Res Commun; 1988 Oct; 156(2):733-9. PubMed ID: 3056402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis and incorporation into protein of norleucine by Escherichia coli.
    Bogosian G; Violand BN; Dorward-King EJ; Workman WE; Jung PE; Kane JF
    J Biol Chem; 1989 Jan; 264(1):531-9. PubMed ID: 2642478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent repression and genetic depression of isoleucine-valine biosynthetic enzymes in Serratia marcescens.
    Kisumi M; Komatsubara S; Chibata I
    J Bacteriol; 1971 Sep; 107(3):824-7. PubMed ID: 4937787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Threonine production by ethionine-resistant mutants of Serratia marcescens.
    Komatsubara S; Kisumi M; Chibata I
    Appl Environ Microbiol; 1983 May; 45(5):1437-44. PubMed ID: 6408983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of methionine in biosynthesis of prodigiosin by Serratia marcescens.
    Qadri SM; Williams RP
    J Bacteriol; 1973 Dec; 116(3):1191-8. PubMed ID: 4201771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of lysine-sensitive aspartokinase in threonine production by S-2-aminoethyl cysteine-resistant mutants of Serratia marcescens.
    Komatsubara S; Kisumi M; Chibata I
    Appl Environ Microbiol; 1979 Nov; 38(5):777-82. PubMed ID: 232391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.